scispace - formally typeset
Open AccessJournal ArticleDOI

Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells:

Paula M. Wagner, +2 more
- 11 Dec 2019 - 
- Vol. 11, pp 1759091419892713
Reads0
Chats0
TLDR
The results suggest that the pharmacological modulation of the tumor-intrinsic clock by REV-ERB agonists severely affects cell metabolism and promotes cytotoxic effects on cancer cells.
Abstract
Glioblastoma multiforme is the most aggressive brain tumor, and human T98G cells constitute a useful glioblastoma multiforme model to evaluate the chemotherapeutic agents. Modern life (shiftwork, j...

read more

Citations
More filters
Journal ArticleDOI

Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation

TL;DR: Wang et al. as mentioned in this paper explored the relationship between dysregulated circadian clock genes and glioma progression, and a cluster and risk model based on circadian clock gene expression can predict survival outcome.
Journal ArticleDOI

Roles of circadian clocks in cancer pathogenesis and treatment.

TL;DR: A review of the role of circadian rhythms in cancer pathogenesis is presented in this article, highlighting the recent advances in chronotherapeutic approaches for improved cancer treatment, and providing mechanistic insights into the therapeutic utility of circadian clocks in cancer treatment.
Journal ArticleDOI

Circadian Rhythms, Disease and Chronotherapy:

TL;DR: A review of recent advances in circadian research and the potential for therapeutic applications that take patient circadian rhythms into account in treating disease can be found in this article, where the authors discuss the importance of functional circadian clocks in modulating cellular and organismal responses to physiological cues and pathological insults.
Journal ArticleDOI

Circadian rhythms and cancers: the intrinsic links and therapeutic potentials

TL;DR: In this paper , the authors provide insights into the mechanisms underlying how several types of disruption of the circadian rhythm (including sleep-wake, eating-fasting, and activity-rest) can drive cancer progression, which may expand our understanding of cancer development from the clock perspective.
References
More filters
Journal ArticleDOI

Hallmarks of cancer: the next generation.

TL;DR: Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Journal ArticleDOI

Autophagy regulates lipid metabolism

TL;DR: A previously unknown function for autophagy in regulating intracellular lipid stores (macrolipophagy) is identified that could have important implications for human diseases with lipid over-accumulation such as those that comprise the metabolic syndrome.
Journal ArticleDOI

The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator.

TL;DR: The orphan nuclear receptor REV-ERBalpha is identified as the major regulator of cyclic Bmal1 transcription, and constitutes a molecular link through which components of the negative limb drive antiphasic expression of component of the positive limb.
Journal ArticleDOI

Circadian Integration of Metabolism and Energetics

TL;DR: Advances in understanding the interrelationship among circadian disruption, sleep deprivation, obesity, and diabetes are reviewed and implications for rational therapeutics for these conditions are reviewed.
Related Papers (5)